Home > Healthcare & Medical Devices > Urodynamic Equipment and Consumables Market
Urodynamic Equipment and Consumables Market size was worth over USD 350 million in 2021. Backed by technological advancements in urodynamic equipment, the industry is expected to grow at around 7% CAGR through the forecast period.
To get more details on this report: Request Free Sample PDF
Rise in the prevalence of lower urinary tract symptoms (LUTS) associated with urological disorders is likely to fuel demand for urodynamic equipment and consumables. Moreover, an increase in the number of patients seeking treatment for BPH and other urological ailments in various healthcare facilities is set to promote market development.
|Market Size in 2021:||350 million (USD)|
|Forecast Period:||2022 to 2030|
|Forecast Period 2022 to 2030 CAGR:||7%|
|2030 Value Projection:||655 million (USD)|
|Historical Data for:||2017 to 2021|
|No. of Pages:||150|
|Tables, Charts & Figures:||197|
|Segments covered:||Product, End-use, and Region.|
|Pitfalls & Challenges:|
To get details on how to order this report click here
High cost of urodynamic equipment is limiting product uptake, particularly in small and independently functioning healthcare institutions. Additionally, stringent regulations and extensive approval processes are further hindering market expansion. Nonetheless, the growing number of patients suffering from chronic urinary diseases, a favorable reimbursement scenario, and increased healthcare spending for urodynamic procedures and other urinary diseases are foreseen to cause an upsurge in product demand.
To tailor this report to your specific requirements: Customize this Report
In terms of product, the urodynamic equipment and consumables market is segmented into uroflowmetry equipment, cystometer, ambulatory urodynamic systems, electromyographs, video urodynamic systems, and urodynamic consumables. The ambulatory urodynamic systems segment was worth more than USD 53 million in 2021 and is estimated to grow at over 7% CAGR from 2022 to 2030. Rising incidents of kidney and bladder ailments, particularly in developing nations, along with increasing adoption in the management and treatment of perioperative indications, is likely to impel product penetration.
To check discounted pricing for this report: Request Discount
The urodynamic equipment and consumables market is divided based on end use into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment was valued at above USD 165 million in 2021 and is projected to progress steadily through 2030 as a result of the increased usage of technologically advanced urodynamic equipment and consumables and the surging availability of treatment alternatives. Growing admissions with target illnesses, such as chronic urinary diseases, as well as easy access to better treatment and diagnostics and the mounting presence of qualified healthcare workers, are foreseen to increase patient visits to hospitals, thereby positively influencing segment outlook.
Europe urodynamic equipment and consumables market is set to reach over USD 160 million by 2030. Rising hospitalization rate due to the high frequency of kidney infections, lower urinary tract ailments, and supportive healthcare policies are slated to accelerate regional business expansion. Additionally, various regulatory measures and screening programs are speculated to significantly boost regional industry share.
Companies operating in the urodynamic equipment and consumables industry include Laborie Medical Technologies, The Prometheus Group, CooperSurgical, Cook Medical, Digitimer Ltd., Verathon Inc., Albyn Medical Ltd., Ambu Inc., MEDKONSULT Medical Technology, SRS Medical, Tic Medizintechnik, HC Italia, Stericom (P3 Medical), and Santron Meditronic. These enterprises are focusing on streamlining procedures and adopting growth strategies to improve their industry standing.
Initially, the COVID-19 pandemic had a negative influence on the urodynamic equipment and consumables business. Several urological treatments, including urodynamic testing, noted a considerable drop in diagnosis and treatment. In 2021, the American Urological Association statistics anticipated that there was around a 50% decline in daily outpatient urology care in the US in February 2020 compared to pre-pandemic levels.
Rising mortality and morbidity rates shifted preferences and priorities toward COVID-19-positive patients, and prevention plans were tailored according to the medical scenario, causing a decline in product demand. However, the decreasing COVID-19 infection rates, as well as increasing procedure volume, are likely to boost global industry development.
The urodynamic equipment and consumables market research report includes in-depth coverage of the industry with estimates & forecast in terms of volume in Million Units and revenue in USD Million from 2017 to 2030 for the following segments:
The above information is provided for the following regions and countries: